Please login to the form below

Wilmington Healthcare makes new senior appointment

Healthcare intelligence provider Wilmington Healthcare, which incorporates Binley’s, NHiS, Wellards and HSJ, has promoted a longstanding employee, Shelley Jessop, to the role of Account Director.

Shelley who has worked for Wilmington Healthcare brands since graduating from university 17 years ago, will be overseeing a number of key accounts and ensuring that the specialist teams meet their objectives.  

Shelley’s most recent post at Wilmington Healthcare was Business Development Director, responsible for all aspects of the sales cycle from identifying new opportunities to negotiating and closing deals.  

Prior to that, Shelley was a sales consultant for Wilmington Healthcare’s NHiS Insight team, which provides business intelligence and insight solutions to the pharma industry.
 

Other posts that Shelley has held for Wilmington Healthcare companies include Business Development Manager and Assistant Research Manager for Binley’s, which provides healthcare data and intelligence to pharma.
       

Gareth Thomas, Managing Director of Wilmington Healthcare, said: “Shelley has enjoyed a long and successful career with Wilmington Healthcare’s brands. I am very pleased to promote her to the role of account director. I know that she will continue to build on the strong relationships she has with her clients and be an extremely valuable asset to our expanding business.” 



                                                                                   Ends   

31st October 2017

Share

Company Details

Wilmington Healthcare

01268 495600

Contact Website

Address:
Beechwood House
2-3 Commercial Way
Christy Close
Southfields
Basildon
SS15 6EF
United Kingdom

Latest content on this profile

How has the pandemic reshaped the NHS in 2020?
Oli Hudson, of Wilmington Healthcare, explores the major changes that have occurred across the NHS as key aspects of the Long Term Plan are rolled out at speed.
Wilmington Healthcare
Harness the power of data to map new patient pathways
Oli Hudson, of Wilmington Healthcare, explains why pharma needs to put data at the heart of its bid to support the NHS Reset
Wilmington Healthcare
How can pharma align its brand strategy with the NHS Reset?
Oli Hudson, of Wilmington Healthcare, explores how pharma should respond to plans to ‘reboot’ the NHS during the covid recovery era
Wilmington Healthcare
Covid-19 redefines rules of customer engagement
Oli Hudson, Content Director at Wilmington Healthcare, explores how the pandemic has changed pharma’s relationship with HCPs
Wilmington Healthcare
White paper helps industry navigate new NHS roadmap
New report shows how pharma can support the NHS in the Covid-19 recovery era
Wilmington Healthcare
Covid-19 drives change in long-term conditions management
Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore how patients are being empowered to manage their conditions at home
Wilmington Healthcare